Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Salman Haq

Internal Medicine Bronx, NY Medical Doctor

NPI 1679524268 CMS profile 257627

392 Bedford Park Blvd, Bronx, NY 10458

Open in the dashboard

General payments

$79,375

399 records reported · program years 2019–2022

Research payments

$600

Paid to them · 2 records reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Salman Haq of Bronx, NY is reported in the CMS Open Payments database as having received $79,375 across 399 general payments and $600 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $2,500 57
2021 General $9,904 90
2020 General $12,346 83
2020 Research $600 2
2019 General $54,625 169

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Salman Haq
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to Salman Haq were reported at $0. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year Salman Haq Internal Medicine median Middle half National median
2019 $54,625 $159 $48–$570 $163
2020 $12,346 $119 $33–$402 $114
2021 $9,904 $135 $37–$521 $132
2022 $2,500 $141 $42–$496 $149
2023 $0 $149 $45–$519 $160
2024 $0 $154 $47–$537 $164
2025 $0 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Boston Scientific Corporation $55,109 94 payments
  2. Medtronic Vascular, Inc. $9,075 32 payments
  3. Medtronic, Inc. $3,765 9 payments
  4. Abiomed $2,395 10 payments
  5. Amgen Inc. $2,028 40 payments
  6. Abbott Laboratories $1,497 48 payments
  7. Bardy Diagnostics, Inc. $878 16 payments
  8. Medical Device Business Services, Inc. $833 7 payments
  9. CVRx, Inc. $627 6 payments
  10. Janssen Pharmaceuticals, Inc $605 28 payments
  11. Other $2,564 109 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $58,068 25 payments
  2. Food and Beverage $12,231 338 payments
  3. Travel and Lodging $5,509 26 payments
  4. Consulting Fee $3,450 5 payments
  5. Education $117 5 payments
Products named General payments · program years 2019–2022
  1. WATCHMAN Structural Heart $50,384 44 payments
  2. Reveal LINQ $5,240 28 payments
  3. WATCHMAN Pain Management $3,127 2 payments
  4. Impella $2,395 10 payments
  5. Repatha $2,028 40 payments
  6. Carnation Ambulatory Monitor $878 16 payments
  7. Carto 3 System $833 7 payments
  8. Accent Pacemaker $750 36 payments
  9. Dragonfly OCT $647 7 payments
  10. Barostim Neo System $627 6 payments
  11. Other $6,294 224 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2022
  1. Medtronic Vascular, Inc. $600 2 payments

Records

401 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record